Skip to main content
. 2017 Nov 17;2017(11):CD005067. doi: 10.1002/14651858.CD005067.pub4
Methods Study design: randomised controlled trial
Setting/location: Iran
Study period: 24 months
Sample size calculation: yes
Participants Type of Leishmania:L major
Inclusion criteria: CL confirmed with direct smear, age 5‐50 years, maximum number of lesions 3, duration of disease < 100 days
Exclusion criteria: previous treatment for leishmaniasis, use of immunosuppressives, history of chronic systemic disease, lesions on face, pregnancy or lactating, age < 5 years, duration of disease > 100 days
N randomised: 197
Withdrawals: 26
N assessed: 171. 96 were treated with garlic 5% cream and 75 with vehicle
Mean age: garlic, 18.5 years; vehicle, 23.7 years
Sex (male/female): garlic, 51/45; placebo, 38/37
Baseline data: not reported
Interventions Type of interventions:
  • Group 1: garlic cream 5%

  • Group 2: vehicle


Duration of intervention: both applied twice daily under occlusion with sterile gauze for 3 hours, for 20 days
Duration of follow‐up: 60 days (after the 3 week treatment, participants were followed for another period of 40 days)
Outcomes Healing rates: percentage of participants 'cured' one month (40 days) after treatment
Time points reported: yes
Notes Study funding sources: none reported
Possible conflicts of interest: none declared
We only have the abstract. The author (A Khamesipour) was contacted and kindly agreed to extract the data from the original paper written in Persian.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk List generated by a computer
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel (performance bias) All outcomes Unclear risk Not described
Blinding of outcome assessment (detection bias) All outcomes Unclear risk Not described
Incomplete outcome data (attrition bias) All outcomes Low risk Low rates of dropouts (26/197; < 25%)
Selective reporting (reporting bias) Unclear risk All relevant outcomes reported
Other bias Unclear risk There was not enough information in the publication to assess if there were other biases present.